Condition: Hypoplastic Left Heart Syndrome · Single Ventricle · Sponsor: Metcela Inc.
The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with functional single ventricle
This description comes directly from the study's public registry record.
Metcela Inc. (former Japan Regenerative Medicine Co., Ltd.) · info@j-rm.com
Always discuss trial participation with your own doctor first.
| Kanagawa Children's Medical Center | Kanagawa, Japan | Recruiting |
| Okayama University Hospital | Okayama, Japan | Recruiting |
| Saitama Prefectural Children's Medical Center | Saitama, Japan | Recruiting |
| Shizuoka Children's Hospital | Shizuoka, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02781922